by stefan | Nov 1, 2021 | Blog, Geen categorie
Oss, The Netherlands, November 1st, 2021 Immagene B.V. today announces it has raised a seed financing round to advance its next-generation precision Immuno-Oncology (IO) therapeutics. BOM Brabant Ventures joined as a new investor with additional support from...
by stefan | Oct 28, 2021 | Blog, Geen categorie
– Expanded investor syndicate strengthens the company’s financial position and investor base ROTTERDAM, October 28, 2021 – Pan Cancer T B.V., a biotech spin-off from the Erasmus MC dedicated to the discovery and development of novel TCR-T therapies against...
by stefan | Dec 21, 2018 | Blog, Geen categorie
TILBURG, The Netherlands, 20 December 2018 – DegenRx B.V. a biopharmaceutical company developing novel therapeutic solutions to treat neurodegenerative diseases, announced today that they have secured financing for their antibody-based gene therapy program for the...
Recent Comments